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Recent work has emphasized the extreme sensitivity of immature B lymphocytes to 
the induction of immunological tolerance (1-3). In newborn mice, a marked lowering 
of splenic B cell responsiveness can be achieved without any demonstrable reduction 
in  either  the  number  of antigen-binding  B  iymphocytes  or  their  antigen-binding 
avidity  spectrum  (4).  Thus,  concentrations  of haptenated-human  gamma  globulin 
(HGG)  too low to saturate,  to blockade, or to modulate the surface immunoglobulin 
(s-Ig) receptors and incapable of eliminating hapten-binding B cells were nevertheless 
sufficient  to effect  the  transmission  of a  negative signal  to the cells which rendered 
them incapable of responding to antigenic or mitogenic stimuli.  Our study examines 
whether the sensitivity threshold for the induction of the anergic state in cells emerging 
from the pre-B (s-Ig negative)  to B cell (s-Ig positive) status during fetal life before the 
development  of immunocompetenee  was  even  lower  than  that  of immature,  but 
already s-Ig positive, B cells  (1,  3) and examines the duration of anergy. 
Materials  and Methods 
Mice.  CBA/CaHWehi mice were used, either 2-3 d of age or as pregnant adults.  (CBA X 
BALB/c)F1 hybrids, aged 4-6 wk, were used as thymus donors. 
Antigens and Tolerance-induction Protocol.  Fluorescein  (FLU)-coupled HGG and  polymerized 
flagellin  (POL) were prepared as previously described (1, 5). Freshly deaggregated FLUsHGG 
was injected intraperitoneally  into newborn mice (2) or intravenously into pregnant  mice at 
14.5 d of gestation (4). 
Estimation of Serum Levels of FLUsHGG.  FLU~HGG was lightly iodinated  with  125I by the 
chloramine-T method, and serum levels estimated by gamma counting. 
Preparation of Cell Suspensions and FLU-Gelatin Fractionation Procedures.  These procedures were 
as previously described (1, 4-6). 
Antibody Formation in  Vitro.  The frequency of clonable anti-FLU plaque-forming cell  (PFC) 
precursors  among unfractionated  and  FLU-gelatin-fractionated  spleen  cell  populations  was 
determined by in vitro limiting-dilution analysis as previously described (1, 6) with either the 
T-independent  antigen  FLU-POL  (0.1 /~g/mi)  or  Escherichia coh  lipopolysaccharide  (LPS) 
(batch 0111 :B4; Difco Laboratories, Detroit, Mich.) (20/~g/ml) to stimulate antibody formation. 
The results  are expressed as a percentage of the frequency value of the saline-injected  (control) 
group. 
Results 
Serum  Tolerogen Levels after a Single Injection.  To enable comparison of the inductive 
phases of in utero (7)  and neonatally induced tolerance, the serum levels achieved by 
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a  single  injection  of tolerogen were determined  for each situation.  Tolerogen doses 
were  chosen  so  that  approximately  equivalent  amounts  were  administered  on  a 
microgram/gram  initial  body weight  basis.  *25I-trace-labeled FLU~HGG was  used, 
with  pregnant  mice  (weighing  ~25  g)  receiving  1 mg  intravenously  at  14.5  d  of 
gestation and newborn mice (weighing ~2 g)  receiving  100 #g intraperitoneally 2-3 
d  after birth.  When  1 mg of tolerogen was administered  maternally,  a  fetal serum 
level of 34/tg/ml was achieved after 24 h and was maintained up to birth and for the 
next 3 d (8) after which it progressively declined (Fig.  1). Similar curves were obtained 
whether  1 mg,  10/tg, or 0.1  #g of trace-labeled FLU-HGG was injected.  When  100 
~g of tolerogen was administered to newborn mice, the 24-h serum level was 143/~g/ 
ml,  declining  to  35/~g/mi  by  7 d.  After  the  initial  equilibration  period,  the  levels 
attained in both groups were similar, the biological half-life of the labeled protein was 
-6-7 d. 
Degree of Tolerance Induced by  Various Doses of Tolerogen.  9 d  after in utero exposure 
(3 d  post-birth) and 7 d after neonatal exposure, the frequency of precursors of anti- 
FLU PFC clones among splenic cells of the treated mice was determined by limiting- 
dilution  analysis in vitro using FLU-POL to stimulate PFC clone formation  (Table 
I). For neonatally induced  tolerance, it was calculated that a  dose of 60 ng of FLU- 
HGG would have achieved a  50% reduction  in  the frequency of clonable anti-FLU 
PFC  splenic  precursors,  which  would  have  resulted  in  an  imputed  peak  serum 
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FIG,  1,  Serum  levels of tolerogen  in  mice at  various periods after administration.  Levels of I~I- 
FLU-HGG  detected in fetal or offspring serum after in utero exposure to a  single maternal dose of 
1 mg injected intravenously into pregnant mice at  14,5 d  of gestation (O)  or in the serum of mice 
after neonatal exposure to  100 p.g injected intraperitoneally 2-3 d  after birth  (0).  Data presented 
for the in utero-exposed group represent  the mean  4-  SE of 6-12  individual values obtained from 
two separate experiments. Neonatal data is derived from a  single experiment, values represent  the 
mean ±  SE of values obtained with six to eight individual mice for each time point. PIKE  ET AL.  BRIEF DEFINITIVE  REPORT  1409 
TABLE  I 
Dose-Response Relationship of lnduced B Cell Tolerance* as Assessed by the Reduction in the Frequency of 
Clonable Anti-Hapten  Precursors 
Dose of FLU-HGG 
injected 
Percentage of control anti-FLU PFC precursor frequency value 
neonatal induction:~  P§  In utero induction:~  P§ 
0  100  --  100  -- 
I mg  ND  --  22.6 ± 4.1  0.005 
100~g  6.42 ±  1.2  0,003  20.3 ± 6.6  0.01 
10~g  11.5 ± 4.4  0.025  21.4 ± 5.1  0.003 
1  ,ttg  21.5 ± 4.l  0.001  26.1 ± 3,1  0.003 
100 ng  45.4 ± 4.8  0.05  32.3 ± 4.3  0.003 
10ng  74.1 ±  13  NS  42.8 ± 5.5  0.005 
1 ng  78.5  NS  55.7 ± 8.1  0.025 
100 pg  ND  --  74.4 ± 7.8  0.05 
* Tolerance was induced either neonatally or in utero as described in Materials and Methods. 
:~ Values given  represent the mean -I- SE of individually normalized percentages of saline-injected control 
frequency values obtained in four to nine experiments. Control frequency values were 39.3 ± 5.22 ×  10  -6 
for neonatal-induction groups and 22.6 ± 4.0 ×  10  -n for in utero-induction groups. ND, not done. 
§ Values represent the significance  of difference from control frequency value, obtained using the Student's 
t test. 
concentration of tolerogen of 86 ng/ml (5.4 X  10  -10 M)  after 24 h  and a  level of 20 
ng/ml  (1.3  ×  10  -l° M)  at  the  time of killing. Doses  _>1  /~g  caused  profound and 
increasing tolerance,  1 or  10  ng resulted  in  insignificant reductions.  For  in  utero- 
induced tolerance, a maternal dose of 2.5 ng would have achieved a  50% reduction in 
the frequency of splenic anti-FLU PFC precursors in the offspring, which would have 
led to a  fetal serum concentration of 80 pg/ml (5.4 ×  10-1aM)  during the period of 
exposure, a  threshold of at least 240-fold lower than the minimum level in neonates. 
Maternal doses >_10 ng resulted in substantial and significant tolerance. 
Failure to  Obtain  Absolute  Tolerance  In  Utero.  In utero,  1 btg caused a  74%  reduction 
in clonable anti-FLU B  cells,  and  1,000-fold  more  tolerogen  did  not  significantly 
increase the degree of tolerance. The possibility that the residual activity was a  result 
ofs-Ig negative, pre-B ceils acquiring immunocompetence  and giving rise to anti-FLU 
PFC clones during the in vitro read-out period was investigated. The fluorescence- 
activated celt sorter (FACS) (BD FACS Systems, Mountain View, Calif.) was used to 
select the s-Ig negative population from spleen cells from 2- to 3-d-old donors. These 
cells were  shown  to  turn  55%  s-Ig  positive within  24  h  in  vitro.  In  vitro  cloning 
analysis using FLU-POL to stimulate antibody formation revealed the frequency of 
anti-FLU PFC precursors among the s-Ig negative spleen cells from both the untreated 
and  1 mg in utero tolerized to be 24% of that of control unfractionated spleen cells. 
This accounted for essentially all of the residual activity (Table I). 
Duration  of Tolerance  Induced  by  a  Single  Injection  of  Tolerogen.  Previous  work  had 
shown that  hapten-binding B  cells could readily be detected  and isolated from the 
spleens of animals tolerized in the perinatal period  (4).  This allowed us to estimate 
the duration ofanergy induced among both the unfractionated spleen cell populations 
and among hapten-specific B cells which were isolated by prefractionation on FLU- 
gelatin-coated dishes (4-6). Newborn mice received a single intraperitoneal injection 
of 100/~g of FLU-HGG, and at  intervals thereafter the frequency of anti-FLU PFC 
precursors among unfractionated and FLU-gelatin prefractionated spleen cells was 1410  PIKE  ET  AL.  BRIEF  DEFINITIVE REPORT 
determined. As expected, profound tolerance resulted (Table II) and this lasted for at 
least  10 wk.  With  a  FLU-POL challenge,  the rate of recovery of responsiveness  in 
unfractionated spleen cells was slightly more rapid than that observed in the higher 
avidity (1) FLU-gelatin binding B cell population. Recovery of responsiveness among 
the FLU-gelatin-binding cells was slightly more rapid when a mitogenic (LPS) rather 
than  antigenic  (FLU-POL)  triggering stimulus  was  used.  From  the  studies  on  the 
serum  levels of circulating  tolerogen  (Fig.  1),  the estimated serum concentration  of 
tolerogen after 10 wk would have been around 80 ng/ml (~5 ×  10  -1° M). Below this 
level tolerance broke down rapidly. 
Discussion 
The demonstration of high-avidity antigen-binding B cells, which are unable to be 
stimulated by either antigen or mitogen, within the spleens of mice rendered tolerant 
in  early  life  (4)  raises  new  perspectives on  the  mechanisms of induction  of B  cell 
tolerance.  We  must  now  ask not  how  a  developing B  cell  can  be eliminated  as  a 
consequence  of premature  contact  with  antigen,  but,  rather,  how  the  B  cell  can 
register and store the negative signals that render it anergic as a result of that contact. 
Our study suggests that the B cell is most sensitive to tolerance induction  at the time 
when  its s-Ig receptors are  first  emerging.  By exposure during  fetal  life before the 
appearance of any s-Ig positive cells in the fetal liver or elsewhere (9), concentrations 
of FLU-HGG as low as 5.4 ×  10  -13 M caused significant tolerance. Neonatal exposure, 
TAnLE  II 
Duration of Tolerance after Neonatal Induction * 
Time after FLU- 
HGG adminis- 
tration 
Percentage of responsiveness of control spleen cells:[: 
Unfractionated + 
FLU-POL§ 
FLU-gelatin binding cellsll 
+  FLU-POL¶  +  LPS** 
wk 
1  9.0 ±  2.0  8.1  +  2.1  9.0 __. 4.8 
2  7.4  10.3  12.6 
4  17.0 ±  9.0  8.5 +  4.5  14.3 +  5.6 
6  34.1 ±  4.3  12.1 ±  2.8  15.9 +  2.4 
8  34.9 ±  2.8  21.3 ±  4.6  38.6  ±  12 
10  38.6~::]:  38.3  70.0 
12  74.9§§  66.1  174 
14  117:1::]:  89.1  105 
* Tolerance was induced neonatally by a single intraperitoneal injection of 100 #g of 
FLU-HGG. 
:~ As measured by enumeration of anti-FLU PFC precursors capable of responding to 
FLU-POL or LPS in vitro. 
§ Precursor frequency values for control groups rose from 40 X  10  -6  at  1 wk (i.e.,  10 
d of age) to the adult levels of 150-200  X  10 -6 at  4-6 wk. 
][ Antigen-binding cells  isolated  from spleens of tolerant  mice by fractionaction on 
FLU-gelatin dishes (4, 6). 
¶ Control  frequency values were 0.6-1%  in  young mice and.  0.8-1.8%  in  the  older 
mice. 
** Control frequency values were 1-3.6% with this stronger stimulus, with no signif- 
icant age variation. 
:}:* Pooled results of two experiments. 
§§ Results of a single experiment. PIKE  ET  AL.  BRIEF  DEFINITIVE  REPORT  1411 
using  2-  to 3-d-old  animals,  which  already  possess significant  numbers  of clonable 
anti-FLU B cells (1, 5), showed the threshold point for significant tolerance induction 
to  be  >240-fold  higher.  In  other  words,  although  immature  B  cells  are  highly 
susceptible to tolerance induction,  their susceptibility is much less than that of cells 
caught in the pre-B to B cell transition phase. We have previously documented (1, 2) 
that adult mature B cells are 250- to 1,000-fold more resistant than immature B cells. 
The  picture  that  emerges then,  is  not  one of an  abrupt  all-or-none change  in  the 
behavior of the  B  cell at  a  particular stage of differentiation,  but,  rather,  one of a 
progressive raising  of the  sensitivity threshold  to  tolerance  induction  as  the  B  cell 
passes through various differentiation stages during ontogenic development. 
The question of how long a B cell can store the negative signals it has accumulated 
is rendered complex because B cells cannot be maintained in tissue culture for long 
periods.  Experiments  on  duration  of tolerance  were  performed  with  a  constantly 
falling level of antigen present in the circulation of living, tolerant animals. It appears 
that neonatally induced tolerance persisted so long as antigen levels remained above 
the threshold that could induce significant tolerance in newborn mice (-80 ng/ml or 
5 X  10  -l° M). However, our results cannot discriminate between a  loss of the anergic 
state in given B cells, or a  failure of induction  of clonal anergy in newly developing 
B cells formed in adult bone marrow, or both. 
The failure to induce tolerance in 20-25% of all the clonable cells in the spleens of 
2- to 3-day old in utero-tolerized mice appears to be a  result of their content of s-Ig 
negative, pre-B cells on the verge of gaining immunoeompetence. These cells, with 
few if any s-Ig receptors thus cannot see the tolerogen in vivo, but are able to acquire 
s-Ig receptors rapidly in vitro, react with the T-independent  immunogen FLU-POL 
and form anti-FLU PFC clones within the 3-d read-out procedure. 
From these studies and previous papers in this series (1, 2), it is now clear that the 
degree of anergy induced  in a  given B cell as a  result of exposure to hapten-HGG is 
a complex function of the maturity of the cell when it first encounters the antigen; the 
molar concentration  of the antigen;  the degree of its muhivalency, which  affects its 
capacity to bind to and cross-link receptors; the length of exposure to the tolerogen; 
and the presence or absence of concomitant stimulating signals. No attempt to explore 
the molecular biology of B lymphocyte signalling can proceed unless each and all of 
these variables are taken into account. 
Summary 
Mice were rendered tolerant to the hapten fluorescein (FLU)  by a single injection 
of FLU-human gamma globulin  (FLU5HGG)  2-3 d  after birth or via the maternal 
circulation at  14.5 d of fetal life. After 7-9 d, the degree of functional nonresponsive- 
ness induced in vivo among splenic FLU-specific B cells of tolerized mice was assessed 
by limiting-dilution analysis in vitro, and the serum levels of trace-labeled tolerogen 
were determined.  When  tolerogen  was introduced  before the  appearance of any B 
cells, and was thus present during the pre-B to B cell transition stage, a concentration 
of 5.4  ×  10  -x3 M  effectively silenced 50% of the clonable anti-FLU  PFC precursors; 
but a  similar reduction  on newborns required  a  minimal tolerogen concentration of 
1.3 x  10  -1° M, >300-fold less than has previously been shown to equally affect adult 
B cells, but at least 240-fold more than in the in utero situation.  Neonatally induced 
tolerance using a relatively high tolerogen dose lasted ~ 12 wk. 1412  PIKE ET  AL.  BRIEF DEFINITIVE REPORT 
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